251
|
Hu X, Ma S, Huang X, Jiang X, Zhu X, Gao H, Xu M, Sun J, Abbott WGH, Hou J. Interleukin-21 is upregulated in hepatitis B-related acute-on-chronic liver failure and associated with severity of liver disease. J Viral Hepat 2011; 18:458-67. [PMID: 21692955 DOI: 10.1111/j.1365-2893.2011.01475.x] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
The immune mechanism(s) that lead to hepatitis B-related acute-on-chronic liver failure (HB-ACLF) are poorly understood. Interleukin-21 is a newly discovered cytokine that is involved in autoimmune and inflammatory diseases. Its potential role in HB-ACLF remains unknown. The serum levels of 12 immune cytokines measured by cytometric bead arrays and the frequency of IL-21-secreting CD4+ T cells in peripheral blood mononuclear cells (PBMC) measured by intracellular cytokine staining were compared in moderate chronic hepatitis B (M-CHB, n = 20), severe chronic hepatitis B (S-CHB, n = 20), HB-ACLF (n = 39) and healthy controls (n = 10). PBMC from M-CHB patients or healthy subjects were stimulated with rhIL-21 in vitro, and cytokines in supernatants were measured by FlowCytomix. The frequencies of IL-21-secreting CD4+ T cells were higher in HB-ACLF (both P < 0.001) and S-CHB (P = 0.002 and 0.001) as compared to M-CHB patients and controls. Serum IL-21 levels were highest (P < 0.001) in HB-ACLF and positively associated with high MELD score (P = 0.001) and mortality (P = 0.038). Recovery from HB-ACLF was associated with reduced serum IL-21 levels (P = 0.003) and lower CD4+ IL-21(+) T-cell frequency (P = 0.006). The secretions of IL-1β (P < 0.001), IL-6 (P < 0.001), IL-10 (P < 0.001), IFN-γ (P = 0.001) and TNF-α (P = 0.042) from PBMC were significantly increased with rhIL-21 stimulation. In summary, IL-21 has a causal role in the development of severe liver inflammation, which is upregulated in HB-ACLF and associated with severity of liver disease.
Collapse
|
252
|
Punyawudho K, Ma S, Van Zee JW, Monnier JR. Effect of O2 on the adsorption of SO2 on carbon-supported Pt electrocatalysts. LANGMUIR : THE ACS JOURNAL OF SURFACES AND COLLOIDS 2011; 27:7524-7530. [PMID: 21608976 DOI: 10.1021/la2000377] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Adsorption of SO(2) in the presence of O(2) on Pt/C catalysts often used as electrocatalysts has been investigated by temperature programmed desorption (TPD) and X-ray photoelectron spectroscopy (XPS). The amounts of SO(2) adsorption on Pt/C in the presence of O(2) were much higher than those in the absence of O(2) (SO(2)-N(2)) and from the carbon support (Vulcan XC-72) alone. Adsorption is dependent on oxygen concentration over the range 0-20% but reaches saturation at 20% O(2). The spillover of SO(2) from Pt to the carbon support has been proposed for 10, 20, and 40% Pt loadings, characterized by desorption temperatures of approximately 150 and 260 °C for SO(2) adsorbed on Pt and carbon, respectively. Adsorbed Pt-S, C-S, C-SO(x), and Pt-SO(4) species were identified by XPS as S-containing species on both Pt and carbon. Both TPD and XPS indicate that the carbon support plays a major role in SO(2) adsorption, primarily as SO(x) (x = 3, 4). The bonding of S and SO(x) on the carbon support was strong enough that back diffusion to the Pt surface did not occur.
Collapse
|
253
|
Mao W, Xu Y, Liu J, Ma S, Zhou X, Chen Q, Zheng X, Du X. Pattern of recurrence after curative surgery in thoracic esophageal squamous cell carcinoma: A 6-year experience with 1,020 patients. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e14557] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
254
|
Ma S, Xu Y, Sun X, Ji Y, Zheng Y, Wang S, Chen J. Endostar in combination with radiotherapy and paclitaxel/carboplatin in patients with unresectable non-small cell lung cancer of stage III: Preliminary results of a phase II study. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.7043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
255
|
Fujita K, Ma S, Aida M, Maeda T, Ikemi T, Hirata M, Nishiyama N. Effect of Reacted Acidic Monomer with Calcium on Bonding Performance. J Dent Res 2011; 90:607-12. [DOI: 10.1177/0022034510397837] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
256
|
Ma S. China searches for best medicine for ailing scientific journals. CMAJ 2011; 183:E25-6. [DOI: 10.1503/cmaj.109-3736] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
257
|
Wang XY, Ma S, Li T, Weng NS. Hydrothermal Synthesis and Crystal Structure of a Novel Pb(II) Coordination Polymer. ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES 2011. [DOI: 10.5560/znb.2011.66b0103] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
258
|
Xu ZL, Ma S, He Y, Kong ZG. Synthesis and Crystal Structure of a New Cd(II) Coordination Polymer Based on a 1,10-Phenanthroline Derivative. ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES 2011. [DOI: 10.5560/znb.2011.66b0538] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
259
|
Chan Wong E, Hatakeyama C, P. Robinson W, Ma S, Vogt PH, Schuettler J, Peng Z, Zimmer J, von Hagens C, Sinn P, Strowitzki T, Wu E, Hatakeyama C, Ma S, Koustas G, Sjoblom C. SELECTED ORAL COMMUNICATION SESSION, SESSION 51: (EPI) GENETICS, Tuesday 5 July 2011 17:00 - 18:00. Hum Reprod 2011. [DOI: 10.1093/humrep/26.s1.51] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
260
|
Acar-Perk B, Weimer J, Koch K, Salmassi A, Arnold N, Mettler L, Schmutzler AG, Ottolini CS, Griffin DK, Handyside AH, Summers MC, Thornhill AR, Montjean D, Benkhalifa M, Cohen-Bacrie P, Siffroi JP, Mandelbaum J, Berthaut I, Bashamboo A, Ravel C, McElreavey K, Ao A, Zhang XY, Yilmaz A, Chung JT, Demirtas E, Son WY, Dahan M, Buckett W, Holzer H, Tan SL, Perheentupa A, Vierula M, Jorgensen N, Skakkebaek NE, Chantot-Bastaraud S, McElreavey K, Toppari J, Muzii L, Magli MC, Gioia L, Mattioli M, Ferraretti AP, Gianaroli L, Koscinski I, Elinati E, Fossard C, Kuentz P, Kilani Z, Demirol A, Gurgan T, Schmitt F, Velez de la Calle J, Iqbal N, Louanjli N, Pasquier M, Carre-Pigeon F, Muller J, Barratt C, Viville S, Magli C, Grugnetti C, Castelletti E, Paviglianiti B, Gianaroli L, Pepas L, Braude P, Grace J, Bolton V, Khalaf Y, El-Toukhy T, Galeraud-Denis I, Bouraima H, Sibert L, Rives N, Carreau S, Janse F, de With LM, Fauser BCJM, Lambalk CB, Laven JSE, Goverde AJ, Giltay JC, De Leo V, Governini L, Quagliariello A, Margollicci MA, Piomboni P, Luddi A, Miyamura H, Nishizawa H, Ota S, Suzuki M, Inagaki A, Egusa H, Nishiyama S, Kato T, Nakanishi I, Fujita T, Imayoshi Y, Markoff A, Yanagihara I, Udagawa Y, Kurahashi H, Alvaro Mercadal B, Imbert R, Demeestere I, De Leener A, Englert Y, Costagliola S, Delbaere A, Velilla E, Colomar A, Toro E, Chamosa S, Alvarez J, Lopez-Teijon M, Fernandez S, Hosoda Y, Hasegawa A, Morimoto N, Wakimoto Y, Ito Y, Komori S, Sati L, Zeiss C, Demir R, McGrath J, Ku SY, Kim YJ, Kim YY, Kim HJ, Park KE, Kim SH, Choi YM, Moon SY, Minor A, Chow V, Ma S, Martinez Mendez E, Gaytan M, Linan A, Pacheco A, San Celestino M, Nogales C, Ariza M, Cernuda D, Bronet F, Lendinez Ramirez AM, Palomares AR, Perez-Nevot B, Urraca V, Ruiz Martin A, Reche A, Ruiz Galdon M, Reyes-Engel A, Treff NR, Tao X, Taylor D, Levy B, Ferry KM, Scott Jr. RT, Vasan S, Acharya KK, Vasan B, Yalaburgi R, Ganesan KK, Darshan SC, Neelima CH, Deepa P, Akhilesh B, Sravanthi D, Sreelakshmi KS, Deepti H, van Doorninck JH, Eleveld C, van der Hoeven M, Birnie E, Steegers EAP, Galjaard RJ, Laven JSE, van den Berg IM, Fiorentino F, Spizzichino L, Bono S, Biricik A, Kokkali G, Rienzi L, Ubaldi FM, Iammarrone E, Gordon A, Pantos K, Oitmaa E, Tammiste A, Suvi S, Punab M, Remm M, Metspalu A, Salumets A, Rodrigo L, Mir P, Cervero A, Mateu E, Mercader A, Vidal C, Giles J, Remohi J, Pellicer A, Martin J, Rubio C, Mozdarani H, Moghbeli Nejad S, Behmanesh M, Alleyasin A, Ghedir H, Ibala-Romdhane S, Mamai O, Brahem S, Elghezal H, Ajina M, Gribaa M, Saad A, Mateu E, Rodrigo L, Martinez MC, Mercader A, Peinado V, Milan M, Al-Asmar N, Pellicer A, Remohi J, Rubio C, Mercader A, Buendia P, Delgado A, Escrich L, Amorocho B, Simon C, Remohi J, Pellicer A, Martin J, Rubio C, Petrussa L, Van de Velde H, De Munck N, De Rycke M, Altmae S, Martinez-Conejero JA, Esteban FJ, Ruiz-Alonso M, Stavreus-Evers A, Horcajadas JA, Salumets A, Bug B, Raabe-Meyer G, Bender U, Zimmer J, Schulze B, Vogt PH, Laisk T, Peters M, Salumets A, Grabar V, Feskov A, Zhilkova E, Sugawara N, Maeda M, Seki T, Manome T, Nagai R, Araki Y, Georgiou I, Lazaros L, Xita N, Chatzikyriakidou A, Kaponis A, Grigoriadis N, Hatzi E, Grigoriadis I, Sofikitis N, Zikopoulos K, Gunn M, Brezina PR, Benner A, Du L, Kearns WG, Shen X, Zhou C, Xu Y, Zhong Y, Zeng Y, Zhuang G, Benner A, Brezina PR, Gunn MC, Du L, Richter K, Kearns WG, Andreeva P, Dimitrov I, Konovalova M, Kyurkchiev S, Shterev A, Daser A, Day E, Turley H, Immesberger A, Haaf T, Hahn T, Dear PH, Schorsch M, Don J, Golan N, Eldar T, Yaverboim R. POSTER VIEWING SESSION - REPRODUCTIVE (EPI) GENETICS. Hum Reprod 2011. [DOI: 10.1093/humrep/26.s1.89] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
261
|
Ma C, Ma S. Various novel erythromycin derivatives obtained by different modifications: recent advance in macrolide antibiotics. Mini Rev Med Chem 2010; 10:272-86. [PMID: 20470243 DOI: 10.2174/138955710791331025] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2010] [Accepted: 01/21/2010] [Indexed: 11/22/2022]
Abstract
The rapid emergence of drug resistance intensified the search for new antimicrobial agents, leading to lots of novel derivatives obtained from 14- and 15-membered macrolides by chemical modifications. Many of them exhibited enhanced antibacterial activity and expanded antibacterial spectrum. Especially some of them were found to be potent for the treatment of multi-drug-resistant bacterial infections. Besides, the other biological effects of macrolide derivatives were also found. In this article, we reviewed the recent advance in the novel macrolide derivatives designed by different structural modifications on erythronolide skeleton, cladinose and desosamine in the structures.
Collapse
|
262
|
Ma S, Hyder A, Bishai D. The political culture of road traffic crash control. Inj Prev 2010. [DOI: 10.1136/ip.2010.029215.629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
263
|
Hyder AA, Trujillo A, Bishai D, Puvanachandra P, Tran N, Chandran A, Ma S, Stevens K. Evaluating road safety interventions: prerequisites for a multi-country approach. Inj Prev 2010. [DOI: 10.1136/ip.2010.029215.598] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
264
|
Ocal P, Sahmay S, Irez T, Senol H, Cepni I, Purisa S, Lin W, Liu X, Donjacour A, Maltepe E, Rinaudo P, Baumgarten MN, Stoop D, Haentjes P, Verheyen G, De Schrijver F, Liebaers I, Camus M, Bonduelle M, Devroey P, Nelissen ECM, Van Montfoort APA, Coonen E, Derhaag JG, Evers JLH, Dumoulin JCM, Costa Lopes JR, Mendes dos Santos J, Portugal Silva Lima S, Portugal Silva Souza S, Rodrigues Pereira T, Barguil Brasileiro JP, Pina H, Lessa ML, Genovese Soares M, Medina Lopes V, Ribeiro CG, Adami K, Hughes C, Emerson G, Grundy K, Kelly P, Mocanu E, Rodrigues Pereira T, Medina Lopes V, Barguil Brasileiro JP, Coelho Cafe T, de Souza Costa JBM, Zavattiero Tierno NI, Portugal Silva Lima S, Portugal Silva Souza S, Mendes dos Santos J, Costa Lopes JR, Rinaudo P, Lin W, Liu X, Donjacour A, Singh S, Vitthala S, Zosmer A, Sabatini L, Tozer A, Davis C, Al-Shawaf T, Neri QV, Monahan D, Rosenwaks Z, Palermo GD, Kalu E, Thum MY, Abdalla HA, Sazonova A, Bergh C, Kallen K, Thurin-Kjellberg A, Wennerholm UB, Griesinger G, Doody K, Witjes H, Mannaerts B, Tarlatzis B, Witjes H, Mannaerts B, Rombauts L, Heijnen E, Marintcheva-Petrova M, Elbers J, Koning A, Mutsaerts MAQ, Hoek A, Mol BW, Fadini R, Guarnieri T, Mignini Renzini M, Comi R, Mastrolilli M, Villa A, Colpi E, Coticchio G, Dal Canto M, Dolleman M, Broer SL, Opmeer BC, Fauser BC, Mol BW, Broekmans FJM, Alama P, Requena A, Crespo J, Munoz M, Ballesteros A, Munoz E, Fernandez M, Meseguer M, Garcia-Velasco JA, Pellicer A, Munk M, Smidt-Jensen S, Blaabjerg J, Christoffersen C, Lenz S, Lindenberg S, Bosch E, Labarta E, Cruz F, Simon C, Remohi J, Pellicer A, Esler J, Osborn J, Boissonnas Chalas C, Marszalek A, Fauque P, Wolf JP, De Ziegler D, Cabanes L, Jouannet P, Han AR, Park CW, Cha SW, Kim HO, Yang KM, Kim JY, Song IO, Koong MK, Kang IS, Roszaman R, Omar MH, Nazri Y, Azantee YW, Murad AZ, Zainulrashid MR, Wang N, Le F, Wang LY, Ding GL, Sheng JZ, Huang HF, Jin F, Reinblatt S, Holzer H, Son WY, Shalom-Paz E, Chian RC, Buckett W, Dahan M, Demirtas E, Tan SL, Revel A, Schejter-Dinur Y, Revel-Vilk S, Hermens RPMG, van den Boogaard E, Leschot NJ, Vollebergh JHA, Bernardus R, Kremer JAM, van der Veen F, Goddijn M, Nahuis MJ, Kose N, Bayram N, Hompes PGA, Mol BWJ, van der veen F, van Wely M, Van Disseldorp J, Broer SL, Dolleman MD, Broeze K, Opmeer BC, Mol BW, Broekmans FJM, De Rycke M, Petrussa L, Liebaers I, Van de Velde H, Cerrillo M, Pacheco A, Rodriguez S, Gomez R, Delagado F, Pellicer A, Garcia Velasco JA, Desmyttere S, Verpoest W, De Rycke M, Staessen C, De Vos A, Liebaers I, Bonduelle M, Kohls G, Ruiz FJ, De la Fuente G, Toribio M, Martinez M, Pellicer A, Garcia-Velasco JA, Soderstrom - Anttila V, Salevaara M, Suikkari AM, Clua E, Tur R, Alcaniz N, Boada M, Rodriguez I, Barri PN, Veiga A, Nelen WLDM, Van Empel IWH, Cohlen BJ, Laven JS, Aarts JWM, Kremer JAM, Ricciarelli E, Gomez-Palomares JL, Andres-Criado L, Hernandez ER, Courbiere B, Aye M, Perrin J, Di Giorgio C, De Meo M, Botta A, Castilla Alcala J, Luceno Maestre F, Cabello Y, Gomez-Palomares JL, Hernandez J, Marqueta J, Pareja A, Hernandez E, Coroleu B, Helmgaard L, Klein BM, Arce JC, Aarts JWM, van Empel IWH, Boivin J, Kremer JAM, Verhaak CM, Ding G, Yin R, Wang N, Sheng J, Huang H, Mancini F, Tur R, Gomez MJ, Rodriguez I, Coroleu B, Barri PN, van den Boogaard NM, van der Steeg JW, van der Veen F, Hompes P, Mol BW, Boyer P, Gervoise-Boyer M, Meddeb L, Rossin B, Audibert F, Sakian S, Chan Wong E, Ma S, Pathak R, Mustafa MD, Ahmed RS, Tripathi AK, Guleria K, Banerjee BD, Vela G, Luna M, Flisser ED, Sandler B, Brodman M, Grunfeld L, Copperman AB, Baronio M, Carrascosa P, Capunay C, Vallejos J, Papier S, Borghi M, Sueldo C, Carrascosa J, Martin Lopez E, Marcucci A, Marcucci I, Salacone P, Sebastianelli A, Caponecchia L, Pacini N, Rago R, Alvarez M, Carreras O, Gomez MJ, Tur R, Coroleu B, Barri PN, Arnoldi M, Diaferia D, Corbucci MG, De Lauretis L, Kook MJ, Jung JY, Lee JH, Jung YJ, Hwang HK, Kang A, An SJ, Kim HM, Kwon HC, Lee SJ, Satoh M, Imada J, Ito K, Migishima F, Inoue T, Ohnishi Y, Kawato H, Nakaoka Y, Fukuda A, Morimoto Y, Mourad S, Hermens RPMG, Nelen WLDM, Grol RPTM, Kremer JAM, Polyzos NP, Valachis A, Patavoukas E, Papanikolaou EG, Messinis IE, Tarlatzis BC, Kang H, Kim CH, Park E, Kim S, Chae HD, Kang BM, Jung KS, Song HJ, Ahn YS, Petkova L, Canov I, Milachich T, Shterev A, Patrat C, Fauque P, Pocate K, Juillard JC, Gayet V, Blanchet V, de Ziegler D, Wolf JP, van der JW, Leushuis E, Steures P, Koks C, Oosterhuis J, Bourdrez P, Bossuyt PM, van der Veen F, Mol BWJ, Hompes PGA. Posters * Safety & Quality (I.E. Guidelines, Multiple Pregnancy, Outcome, Follow-Up etc.). Hum Reprod 2010. [DOI: 10.1093/humrep/de.25.s1.310] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
265
|
Jung Y, Ho S, Yu S, Wu S, Zhang Y, Xu L, Dai Y, Teng Y, Ma S, Song S. A phase II clinical study of interleukin-11 mutein to treat patients with chemotherapy-induced thrombocytopenia. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.9113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
266
|
Ma S, Xu Y, Ji Y, Sun X, Cheng J, Du X, Zheng Y, Qiu G. Concomitant pemetrexed/carboplatin chemotherapy and 3D conformal radiotherapy followed by pemetrexed/carboplatin consolidation chemotherapy for locally advanced non-small cell lung cancer: Preliminary results of a phase II study. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.7092] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
267
|
Gao EJ, Liu HY, Zhu MC, Liu FC, Huang Y, Ma S, Shi QZ, Wang L. A novel 3D lead(II) organometallic framework with four lead(II) nuclei as a secondary building unit: Synthesis and characterization. RUSS J COORD CHEM+ 2009. [DOI: 10.1134/s1070328409120070] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
268
|
Gao EJ, Ma S, Huang Y, Liu HY, Liu FC, Shi QZ. Synthesis and crystal structure of a Cu(II) complex Cu2(Endc)2(Bipy)2 and its photoluminescence properties. RUSS J COORD CHEM+ 2009. [DOI: 10.1134/s107032840910011x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
269
|
Ma S, Sun H, Chen Z, Dutta NK. High speed all-optical PRBS generation based on quantum-dot semiconductor optical amplifiers. OPTICS EXPRESS 2009; 17:18469-18477. [PMID: 20372577 DOI: 10.1364/oe.17.018469] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
A scheme to generate return-to-zero on-off keying (RZ-OOK) high speed all-optical pseudo random bit sequence (PRBS) based on quantum-dot semiconductor optical amplifiers (QD SOA) has been studied. By analyzing the performance of the core functional unit of this system, which is composed of QD SOA-based logic XOR and AND gates, as well as considering the saturation effect of the QD device and noise level of the system, we demonstrated the system's capability of producing stable high speed optical PRBS signals. Results show that the performance of the system depends on a number of parameters, including relaxation lifetime from QD excited state to ground state, injected current density, bit repetition rate, signal pulse width and single pulse energy. For devices with relaxation time approximately 1.0 ps, injected current density >1.8 kA/cm(2), single pulse energy <1.0 pJ with pulse width around 1.0 ps, the system is capable of PRBS generation at speeds of approximately 250 Gb/s.
Collapse
|
270
|
Tang SS, Gao H, Zhao Y, Ma S. Aneuploidy and DNA fragmentation in morphologically abnormal sperm. ACTA ACUST UNITED AC 2009; 33:e163-79. [DOI: 10.1111/j.1365-2605.2009.00982.x] [Citation(s) in RCA: 53] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
271
|
Brandsma M, Wang X, Diao H, Kohalmi S, Jevnikar A, Ma S. A Proficient Approach to the Production of Therapeutic Glucagon-Like
Peptide-1 (GLP-1) in Transgenic Plants. ACTA ACUST UNITED AC 2009. [DOI: 10.2174/1874070700903010057] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Glucagon-like peptide-1 (GLP-1) is a small peptide hormone with potent insulinotropic activity and represents
a promising new therapeutic tool for the treatment of diabetes. Like many other therapeutic peptides, GLP-1 is commonly
produced using chemical synthesis methods, but is limited by product quantity and cost. The advent of recombinant DNA
technology offers the possibility of producing GLP-1 inexpensively and in vast quantities. In this study, transgenic plants
were used as a recombinant expression platform for the production of GLP-1 as a large multimeric protein. A synthetic
gene encoding ten sequential tandem repeats of GLP-1 sequence (GLP-1x10) was produced and introduced into tobacco
plants. Transcriptional expression of the GLP1x10 gene in transgenic plants was confirmed by RT-PCR. Western blot
analysis showed that the GLP-1x10 protein efficiently accumulated in transgenic plants, with an accumulation level as
high as 0.15% of total soluble protein in leaves. Importantly, insulin secretion assays using a mouse pancreatic β cell line
(MIN6), showed that plant-derived GLP-1 in its synthetic decamer form, retained its ability to stimulate cellular insulin
secretion, although with reduced efficacy. These results demonstrate that transgenic plants are an efficient system for the
production of a multimerized recombinant GLP-1. Moreover, transgenic plants synthesizing high levels of GLP-1x10 may
prove to be an attractive delivery system for direct oral administration of a novel stable GLP-1 analog in the treatment of
patients with Type 2 diabetes.
Collapse
|
272
|
Ma S, Fujita (Nakajima) K, Nishiyama N. Effects of Storage Temperature on the Shelf Life of One-step and Two-step Self-etch Adhesives. Oper Dent 2009; 34:472-80. [DOI: 10.2341/08-010-l] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Clinical Relevance
Storage temperature affects the alteration rate of one-step adhesives for all-in-one adhesive systems and self-etching primer for two-step adhesive systems. Their shelf life is strongly dependent on the storage temperature and time period. Storage under 20°C extends their shelf life.
Collapse
|
273
|
Li F, Chai ZG, Sun MN, Wang F, Ma S, Zhang L, Fang M, Chen JH. Anti-biofilm effect of dental adhesive with cationic monomer. J Dent Res 2009; 88:372-6. [PMID: 19407160 DOI: 10.1177/0022034509334499] [Citation(s) in RCA: 98] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
The incorporation of polymerizable cationic monomers has been attempted to generate dental resinous materials with antibacterial activity. This study tested the hypothesis that a dental adhesive containing a cationic monomer, methacryloxylethyl cetyl dimethyl ammonium chloride (DMAE-CB), would influence biofilm formation and gtf gene expression of Streptococcus mutans. The effect of the photo-polymerized DMAE-CB-incorporated adhesive on in vitro biofilm accumulation was investigated with spectrophotometry and scanning electron microscopy. The relative level of gtf gene expression by Streptococcus mutans in the biofilm was quantified by real-time reverse-transcription polymerase chain-reaction. The DMAE-CB-incorporated adhesive significantly decreased bio-film accumulation on its surface (P < 0.05), and suppressed the expression of gtfB and gtfC of Streptococcus mutans in the biofilm (P < 0.05). The results suggest that the cured DMAE-CB-incorporated adhesive may hamper biofilm accumulation via selective down-regulation of the expression of gtf genes in Streptococcus mutans.
Collapse
|
274
|
Ma S, Xu Y, Yu X. Concomitant pemetrexed/carboplatin chemotherapy with 3-D conformal radiotherapy followed by pemetrexed/carboplatin consolidation chemotherapy in locally advanced non-small cell lung cancer in a Chinese population. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e18502] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e18502 Background: Pemetrexed in combination with carboplatin has been shown to have promising activity, as well as superior toxicity profile in advanced non-small cell lung cancer(NSCLC). Radiotherapy(RT) has been shown to improve survival of patients with locally advanced NSCLC when combined with other platin doublets. This phase II study of concomitant pemetrexed/carboplatin chemotherapy(CT) with 3-D conformal RT followed by pemetrexed/carboplatin consolidation CT in locally advanced NSCLC was designed to evaluate the efficacy and safety of this novel regimen. This report presents preliminary information of 10 patients who have completed treatment. Methods: 10 chemoradiation (CRT)-naive and stage IIIA or IIIB (not effusion) with KPS≥80 patients were included in this study between February 2008 and October 2008. Patients received pemetrexed 500 mg/m2, carboplatin AUC 5 CT repeated q3 weeks for 2 cycles concomitant with RT and 3 cycles of consolidation pemetrexed (500 mg/m2) and carboplatin (AUC=5) q3 weeks. Median total dose of RT, without elective nodal irradiation, was 62 Gy (range: 60-66 Gy) with 2 Gy daily fractions. Results: 1 (10%) and 8 patients (80%) had a complete or partial response respectively, while 1 patient(10%) had progression of the disease(brain metastases). The overall response rate (90%,95% confidence interval (CI): 68%-97%) exceeded the goal per study design. After concomitant CRT, the main toxicity was neutropenia, with a median ANC nadir of 1.6, three patients had Grade 3 neutropenia, One patient had Grade 4 neutropenia. Grade 3 thrombocytopenia was seen in one patient, grade 3 esophagitis in one patient and grade 3 radiation pneumonitis in one patient. Consolidation CT was not administered to 3 patients- one due to the development of brain metastases during the first month after chemoradiation, one due to patient refusal and one due to grade 3 radiation pneumonitis. Conclusions: This preliminary data suggests that concomitant treatment was well tolerated, with promising activity and a significant improvement of QoL in a Chinese population with locally advanced NSCLC. No significant financial relationships to disclose.
Collapse
|
275
|
Xu Y, Ma S, Yu D, Wang J, Zhang L, Di X. FDG-PET/CT imaging for staging and definition of tumor volumes in radiation treatment planning in non-small cell lung cancer. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.7574] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
7574 Background: 18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) /computed tomography (CT) has a potential improvement for staging and radiation treatment (RT) planning of various tumor sites. But from a clinical standpoint, the open questions are essentially the following: to what extent does PET/CT change the target volume? Can PET/CT reduce inter-observer variability in target volume delineation? We analyzed the use of FDG-PET/ CT images for staging and evaluated the impact of FDG- PET/CT on the radiotherapy volume delineation compared with CT in patients with non-small cell lung cancer (NSCLC) candidates for radiotherapy. Intraobserver variation in delineating tumor volumes was also observed. Methods: Twenty-three patients with stage I-III NSCLC were enrolled in this pilot study and were treated with fractionated RT based therapy with or without chemotherapy. FDG-PET/CT scans were acquired within 2 weeks prior to RT. PET and CT data sets were sent to the treatment planning system Pinnacle through compact disc. The CT and PET images were subsequently fused by means of a dedicated radiation treatment planning system. Gross Tumor Volume (GTV) was contoured by four radiation oncologists respectively on CT (CT-GTV) and PET/CT images (PET/CT-GTV). The resulting volumes were analyzed and compared. Results: For the first phase, two radiation oncologists outlined together the contours achieving a final consensus. Based on PET/CT, changes in TNM categories occurred in 8/23 cases (35%). Radiation targeting with fused FDG-PET and CT images resulted in alterations in radiation therapy planning in 12/20 patients (60%) by comparison with CT targeting. The most prominent changes in GTV have been observed in cases with atelectasis. For the second phase was four intraobserver variation in delineating tumor volumes. The mean ratio of largest to smallest CT-based GTV was 2.31 (range 1.01–5.96). The addition of the PET data reduced the mean ratio to 1.46 (range 1.12–2.27). Conclusions: PET/CT fusion images could have a potential impact on both tumor staging and treatment planning. Implementing matched PET/CT reduced observer variation in delineating tumor volumes significantly with respect to CT only. [Table: see text]
Collapse
|